Related Experiment Video
Updated: Jul 27, 2026
08:50
Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
Published on: April 9, 2018
A comparative study on the solid phase capture--platelet test, platelet adhesion immunofluorescence test and
1Department of Hematology, First Affiliated Hospital, Zhejiang Medical University, Hangzhou.
Chinese Medical Journal
|July 1, 1993
Summary
The solid phase capture-platelet test (CPT) offers higher sensitivity and easier handling for antibody screening compared to other methods. While less specific than the lymphocytotoxic test (LCT), CPT provides efficient identification of HLA and platelet-specific antibodies.
Area of Science:
- Immunology
- Serology
- Clinical Diagnostics
Background:
- Accurate antibody detection is crucial for clinical diagnostics, particularly in transplantation and transfusion medicine.
- Existing methods like the platelet adhesion immunofluorescence test (PAIFT) and lymphocytotoxic test (LCT) have limitations in sensitivity, specificity, or ease of use.
- The solid phase capture-platelet test (CPT) was developed to address these challenges in antibody screening.
Purpose of the Study:
- To compare the sensitivity, specificity, and reproducibility of the solid phase capture-platelet test (CPT) against the platelet adhesion immunofluorescence test (PAIFT) and the lymphocytotoxic test (LCT).
- To evaluate the practical advantages of CPT in terms of handling and antibody identification capabilities.
Main Methods:
- Comparative analytical study evaluating three distinct immunological assays: CPT, PAIFT, and LCT.
- Statistical analysis was performed to compare sensitivity (P < 0.001 for CPT vs PAIFT; P < 0.01 for CPT vs LCT) and specificity (P < 0.01 for CPT vs LCT).
- Reproducibility was assessed for CPT and PAIFT, yielding 100% and 92% respectively.
Main Results:
- CPT demonstrated significantly higher sensitivity compared to both PAIFT and LCT.
- CPT exhibited lower specificity (86%) than LCT (100%).
- Reproducibility was comparable between CPT (100%) and PAIFT (92%).
- CPT proved easier to handle than PAIFT and LCT.
- CPT effectively identified both HLA and platelet-specific antibodies.
Conclusions:
- The solid phase capture-platelet test (CPT) is a highly sensitive and reproducible assay for antibody screening.
- CPT offers practical advantages in handling and broad antibody identification capabilities, making it an efficient diagnostic tool.
- While LCT remains superior in specificity, CPT presents a valuable alternative for comprehensive antibody detection in clinical immunology.
